Table 3.
Disease severity, treatment, and prognosis of COVID-19 patients.
| Variable | Total (N = 258) |
DM (n = 63) |
Non-DM (n = 195) |
P |
|---|---|---|---|---|
| Severity, n (%) | ||||
| Mild to moderate | 87 (33.7) | 18 (28.6) | 69 (35.4) | 0.028 |
| Severe | 116 (45.0) | 24 (38.1) | 92 (47.2) | |
| Critical | 55 (21.3) | 21 (33.3) | 34 (17.4) | |
| Complications, n (%) | ||||
| Acute respiratory distress | 62 (24.0) | 24 (38.1) | 38 (19.5) | 0.001 |
| Acute cardiac injury | 19 (7.4) | 9 (14.5) | 10 (5.1) | 0.016 |
| Acute kidney injury | 7 (2.7) | 3 (4.8) | 4 (2.1) | 0.250 |
| Medication, n (%) | ||||
| Antiviral agent | 246 (95.3) | 60 (95.2) | 186 (95.4) | 0.962 |
| Antibiotic | 162 (62.8) | 47 (74.6) | 115 (59.0) | 0.026 |
| Corticosteroid | 74 (28.7) | 17 (27.0) | 57 (29.2) | 0.792 |
| Oxygen support, n (%) | ||||
| Nasal cannula | 148 (57.4) | 30 (47.6) | 118 (60.5) | 0.037 |
| High-flow oxygen | 24 (12.4) | 8 (12.7) | 24 (12.3) | |
| Non-invasive ventilation | 26 (10.1) | 10 (15.9) | 16 (8.2) | |
| Invasive mechanical ventilation | 16 (6.2) | 7 (11.1) | 9 (4.6) | |
| ECMO | 1 (0.4) | 1 (1.6) | 0 (0) | |
| Prognosis, n (%) | ||||
| Discharged | 87 (33.7) | 16 (35.7) | 71(36.4) | 0.039 |
| Not discharged yet | 156 (60.5) | 40 (63.5) | 116 (59.5) | |
| Death | 15 (5.8) | 7 (11.1) | 8 (4.1) | |
DM, diabetes mellitus; ECMO, extracorporeal membrane oxygenation.